The Pentagon quickly reversed its decision on a new testosterone screening initiative just one day after announcing it, as the Department of War looks to revise the program.
The original proposal called for “mandatory screening for testosterone deficiency” among male service members aged 30 and older, as stated by Pentagon spokesman Sean Parnell on July 15. Medical experts expressed concerns about potential serious side effects of Testosterone Replacement Therapy, although some individuals genuinely benefit from it, according to the Daily Caller News Foundation.
Dirk Vanderschueren, an andrologist from UZ Leuven and KU Leuven in Belgium, voiced his surprise at the plan, saying, “I thought, ‘What is going on here?’ There is a rare disorder related to deficiency, but it’s not common at all.”
Martin Miner, co-director at the Brown University Men’s Health Center, noted that treating men with low testosterone could lead to infertility, which is particularly concerning for younger men who may wish to preserve their reproductive capabilities.
An instance that illustrates this risk involves online personality Braden Peters, also known as Clavicular, who has claimed that his use of testosterone and anabolic steroids resulted in infertility, as reported by Vox.
Interestingly, not all medical professionals criticized the Department of War’s (DOW) proposed screening framework. Wayne Hellstrom, urology professor and chief of andrology at Tulane University School of Medicine, commented that screening newcomers to the military could be beneficial in identifying those who may require supplementation. He acknowledged the challenges in setting uniform thresholds for what constitutes normal testosterone levels.
On September 2, the Defense Health Agency issued guidance regarding the program, outlining new screening and treatment processes as effective immediately. Yet, the following day, the guidance and the related Pentagon statement were removed from official government channels.
A U.S. official informed DCNF that the draft titled “Clinical Guidance for Health and Human Performance Optimization” had been temporarily rescinded for updates, although the “Interim Guidance on Testosterone Deficiency Screenings for Active Duty and Reserve Component Personnel” remains active.
This proposal clashes with existing recommendations from the Endocrine Society, which maintains that there is not enough evidence to support widespread testosterone screening for asymptomatic men. They advocate for diagnosing hypogonadism only in patients displaying relevant symptoms and consistently low testosterone readings.
The Pentagon introduced its “Warfighter Performance Optimization – Total Force Fitness” initiative through a memorandum from Secretary of War Pete Hegseth on May 6, aiming to develop methods that enhance the capabilities of military teams.
Secretary Hegseth emphasized that the initiative focuses on optimizing natural capabilities rather than artificial enhancement. Effective immediately, the program would screen service members over 30 for testosterone deficiencies, with younger members allowed to opt-in.
Low testosterone can lead to diminished libido, erectile dysfunction, infertility, loss of muscle mass, brittle bones, and anemia, per the National Library of Medicine.
Tobias Köhler, a urology professor at Mayo Clinic, suggests that a baseline testosterone check in young, healthy individuals is wise, but emphasizes that simply feeling well is often enough reason to avoid unnecessary treatment.
Köhler explained that different men have varying baseline testosterone levels and knowing one’s normal range is crucial when evaluating any changes.
While most individuals may not require Testosterone Replacement Therapy, experts acknowledge substantial life improvements for those who do, especially if treated in a way that boosts natural production rather than resorting to direct testosterone injections.
Miner described positive outcomes from treatment, noting significant improvements in energy levels, mood, and even muscle mass over time.
If a screening indicated low levels, the Pentagon’s earlier guidance mandated that further tests and an assessment of symptoms be conducted before beginning hormone therapy.
Despite divided opinions among medical specialists regarding the screening’s value, there seems to be a consensus that health issues in the U.S. are contributing to decreasing testosterone levels in American men.
Miner remarked on the broader health challenges affecting service members, linking obesity and metabolic syndrome—conditions like high blood pressure and abnormal blood sugar levels—with a decline in testosterone, exacerbated by stress and sleep deprivation common in combat situations.
